University Hospital Essen

location_on Essen, Germany
9.6/10 from 23 Votes

Department of Nuclear Medicine (290003)

Ken Herrmann

Prof. Dr. med.

Ken Herrmann

Specialized in: nuclear medicine

About the department

The Department of Nuclear Medicine at the University Hospital Essen offers the full range of radioisotope diagnostics and treatment. Of particular interest is the detection and treatment of thyroid diseases, endocrine tumors. The department also specializes in radioiodine therapy for the treatment of thyroid diseases, radionuclide therapy for bone metastases, MIBG therapy for the treatment of neuroblastomas, malignant pheochromocytes and many other therapies. In addition, the department operates its own Radiopharmaceutical Section, which produces radiopharmaceuticals for two positron emission tomography (PET) scanners. The department is headed by Prof. Dr. med. Ken Herrmann.

The diagnostic and therapeutic service range of the department includes:

  • Diagnostic examinations
    • Thyroid gland diagnostics
      • Ultrasound examinations of the thyroid gland (high resolution)
      • Thyroid scintigraphy
      • Fine needle aspiration biopsy
      • Laboratory tests
    • PET and PET-CT cancer diagnostics
    • Kidney scintigraphy
    • Lung scintigraphy
    • Heart diagnostics
      • Myocardial scintigraphy
      • Heart scintigraphy
      • 18F-FDG-PET  
    • Skeletal scintigraphy
    • Gastrointestinal diagnostics
      • Salivary gland scintigraphy
      • Esophageal scintigraphy
  • Treatment methods
    • Radioiodine therapy for the treatment of thyroid hyperfunction, diffuse goiter, thyroid malignant tumors
    • DOTATOC therapy for the treatment of neuroendocrine tumors
    • Lu-177 PSMA therapy for the treatment of metastatic prostate cancer
    • MIBG therapy for the treatment of neuroendocrine tumors, for example, malignant pheochromocytoma and neuroblastoma, neuroendocrine tumors of the digestive tract and other rare tumors, such as medullary thyroid carcinoma
    • Selective internal radiation therapy (SIRT) with 90Y microspheres for the treatment of hepatocellular carcinoma, liver metastases in breast cancer, neuroendocrine tumors and colorectal cancer
    • Intracavitary therapy with citrate colloid (90Y) in recurrent malignant ascites
    • Zevalin therapy (90Y), for example, for the treatment of CD20 positive non-Hodgkin's lymphoma
    • Radionuclide pain therapy in bone metastases
  • Other diagnostic and therapeutic options

Curriculum vitae

Professional Activities

  • 1997 - 2004 Study of Medicine at the Charite Medical School in Berlin.
  • Internships in France, Switzerland, Chile and USA.
  • 2009 - 2011 Magistracy in Business Administration at the University of Zurich (without leaving the main activities).
  • Training for a Medical Specialist at the University Hospital Rechts der Isar Munich at the Technical University of Munich.
  • 2011 - 2015 Visiting Assistant Professor at the University of California, Los Angeles.
  • 2012 - 2016 Managing Senior Physician and Deputy Head of the Department of Nuclear Medicine at the University Hospital Würzburg.
  • 2015 - 2016 Assistant Professor and Head of the Ahmanson Translational Imaging Division at the University of California, Los Angeles.
  • Since 2016 to the present time, Associate Professor at the University of California in Los Angeles.
  • Since 2016 Head of the Department of Nuclear Medicine at the University Hospital Essen.

Clinical Focuses

  • Diagnostics and treatment of thyroid diseases (especially cancer).
  • Diagnostics and treatment of other endocrine tumors (Ga-68 Dotatoc therapy, I-124 MIBG therapy).
  • Diagnostics (Ga-68 PSMA-PET/CT) and prostate cancer therapy (Lu-177 PSMA therapy).
  • Selective intraarterial radionuclide therapy (SIRT) in liver tumors.
  • PET Center with two PET/CT and one PET/MRI.

Research Focuses

  • Development and application of new radiopharmaceuticals.
  • Diagnostics and treatment of thyroid cancer.
  • Diagnostics and treatment of endocrine tumors.
  • Diagnostics and treatment of prostate cancer.
  • Clinical use, optimization of PET, PET/CT.

Membership in Professional Societies

  • Member of the European Association of Nuclear Medicine (EANM).
  • Member of the Imaging Group, European Organisation for the Research and Treatment of Cancer (EORTC).
  • DRG Committee Member, German Society of Nuclear Medicine.

Photo of the doctor: (c) Universitätsklinikum Essen 

Department of Nuclear Medicine.
University Hospital Essen:

Request more information now.
We will be happy to answer all your questions.


Need Help?

Thank you!

We received your treatment application in the best Europe clinics. Our manager will contact you within the next 24 hours.